DPP-4 drugs for Type 2 Diabetes
16 tracked DPP-4 drugs in the Type 2 Diabetes race. The class explanation lives on the DPP-4 page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.
4 approved / phase 411 Phase 31 Phase 1
Head-to-head evidence: Alogliptin vs Anagliptin · Alogliptin vs Cofrogliptin · Alogliptin vs Evogliptin · Alogliptin vs Gemigliptin · Alogliptin vs Gosogliptin · Alogliptin vs Linagliptin